Federal projects are rolling out A.I. agents that offer therapy and prescribe medicine, raising concerns about safety and the influence of venture capital investors.
Please enable JS and disable any ad blocker
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | As AI fears spike, Trump bats down calls for regulation | 0 | 6.4 | 14-09-2026 |
| 2 | FDA considers doctor-like ‘competency-based’ tests for medical generative AI | 0 | 13.25 | 20-08-2026 |
| 3 | AI's growing role in rulemaking raises new transparency questions | 0 | 10 | 28-07-2026 |
| 4 | Agentic-AI tool aims to give US commanders new target options ‘within seconds’ | 0 | 6 | 28-06-2026 |
| 5 | Wall Street is growing increasingly uneasy at the AI investment bubble | 0 | 10 | 30-07-2026 |
| 6 | Donald Trump’s AI regime is opaque, unpredictable—and unsustainable | -5 | 6 | 30-06-2026 |
| 7 | The debate over AI has taken over Washington | 0 | 8.26 | 17-09-2026 |
| 8 | Feds want feedback on AI-enabled medical device regulation | 0 | 14.49 | 19-08-2026 |
| 9 | Trump redoubles pro-AI stance amid calls to slow development | 0 | 9.28 | 14-09-2026 |